Everstone invests in India's Translumina
The Everstone Group has invested in Translumina Therapeutics, a global manufacturer of medical devices based in India.
The size of Everstone’s commitment has not been disclosed, though Indian media reported that the GP paid INR5 billion ($69.7 million) for a significant minority stake. The investment is aimed at helping...
More on South Asia
Latest News
PE investors wary of inflation in 2022 - AVCJ Forum
Inflation is top of mind for Asia-focused private equity investors as they assess the various uncertainties facing the industry in 2022, the AVCJ Private Equity & Venture Forum heard.
Legend hits first close on healthcare fund, launches TMT vehicle
Legend Capital has reached a first close of $177 million on its third US dollar-denominated China healthcare fund. It is one of five vehicles the GP has in the market, including its recently launched ninth flagship technology, media, and telecom (TMT)...
Qiming leads $40m round for Allorion Therapeutics
China and US-based precision medicine company Allorion Therapeutics has raised a $40 million Series A round led by Qiming Venture Partners.
Japan space debris start-up Astroscale gets $109m Series F
Astroscale, a Japanese space tech start-up dedicated to cleaning up orbital debris, has raised $109 million in Series F funding from investors including London-listed Seraphim Space Investment Trust, Japan Growth Capital Investment, and Axa Life Insurance.